Department of Surgery, Chungbuk National University Hospital, Cheongju, Korea.
Ann Surg Oncol. 2013 Jul;20(7):2317-27. doi: 10.1245/s10434-012-2700-0. Epub 2013 May 16.
Current rates of survival for gastric cancer patients are much improved compared with those of the past. The purpose of our study was to analyze the survival of gastric cancer patients according to time period and to examine how different prognostic factors are related to changing survival rates.
We analyzed data from 7,757 patients who underwent curative gastrectomy after diagnoses of gastric cancer at Samsung Medical Center from 1994 to 2006. Clinicopathologic characteristics and prognostic factors were analyzed retrospectively, with patients divided into period I, from 1994 to 2001, and period II, from 2002 to 2006.
The 5-year, disease-free survival rate of patients with gastric cancer increased significantly from 76.7 % during period I to 85.9 % during period II (p < 0.001). The prognosis of the patient who underwent surgery during period I was worse than that of the patient in period II. When multivariate analyses were performed for each time period, independent prognostic factors for period I included patient age >60 years, tumor located in the whole stomach, tumor size, stage, vascular invasion, perineural invasion, and adjuvant chemotherapy. For period II, tumor size, vascular, and adjuvant chemotherapy were no longer independent prognostic risk factors.
The disease-free survival of gastric cancer improved and prognostic factors changed over time. Active, concurrent chemoradiotherapy together with radical gastric resection performed by an expert surgeon seemed to contribute to the improvement in the survival rates of gastric cancer.
与过去相比,目前胃癌患者的生存率有了很大提高。我们研究的目的是根据时间阶段分析胃癌患者的生存情况,并检查不同的预后因素与生存率变化的关系。
我们分析了 1994 年至 2006 年在三星医疗中心接受根治性胃切除术的 7757 例胃癌患者的数据。回顾性分析了临床病理特征和预后因素,并将患者分为第一期(1994 年至 2001 年)和第二期(2002 年至 2006 年)。
胃癌患者的 5 年无病生存率从第一期的 76.7%显著提高到第二期的 85.9%(p<0.001)。第一期接受手术的患者的预后比第二期的患者差。对每个时期进行多变量分析时,第一期的独立预后因素包括患者年龄>60 岁、肿瘤位于整个胃、肿瘤大小、分期、血管侵犯、神经周围侵犯和辅助化疗。对于第二期,肿瘤大小、血管和辅助化疗不再是独立的预后危险因素。
胃癌的无病生存率随着时间的推移而提高,预后因素也发生了变化。积极的同期放化疗联合专家外科医生进行的根治性胃切除术似乎有助于提高胃癌的生存率。